227 related articles for article (PubMed ID: 16537666)
21. Association of the transfer coefficient of the lung for carbon monoxide with emphysema progression in male smokers.
Mohamed Hoesein FA; Zanen P; van Ginneken B; van Klaveren RJ; Lammers JW
Eur Respir J; 2011 Nov; 38(5):1012-8. PubMed ID: 21565924
[TBL] [Abstract][Full Text] [Related]
22. A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy.
Dirksen A; Dijkman JH; Madsen F; Stoel B; Hutchison DC; Ulrik CS; Skovgaard LT; Kok-Jensen A; Rudolphus A; Seersholm N; Vrooman HA; Reiber JH; Hansen NC; Heckscher T; Viskum K; Stolk J
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1468-72. PubMed ID: 10556107
[TBL] [Abstract][Full Text] [Related]
23. Lung function and CT lung densitometry in 37- to 39-year-old individuals with alpha-1-antitrypsin deficiency.
Mostafavi B; Diaz S; Piitulainen E; Stoel BC; Wollmer P; Tanash HA
Int J Chron Obstruct Pulmon Dis; 2018; 13():3689-3698. PubMed ID: 30510411
[TBL] [Abstract][Full Text] [Related]
24. The effects of radiation dose and CT manufacturer on measurements of lung densitometry.
Yuan R; Mayo JR; Hogg JC; Paré PD; McWilliams AM; Lam S; Coxson HO
Chest; 2007 Aug; 132(2):617-23. PubMed ID: 17573501
[TBL] [Abstract][Full Text] [Related]
25. Lung Function and CT Densitometry in Subjects with alpha-1-Antitrypsin Deficiency and Healthy Controls at 35 Years of Age.
Piitulainen E; Montero LC; Nystedt-Düzakin M; Stoel BC; Sveger T; Wollmer P; Tanash HA; Diaz S
COPD; 2015 Apr; 12(2):162-7. PubMed ID: 25280185
[TBL] [Abstract][Full Text] [Related]
26. Lung density associates with survival in alpha 1 antitrypsin deficient patients.
Green CE; Parr DG; Edgar RG; Stockley RA; Turner AM
Respir Med; 2016 Mar; 112():81-7. PubMed ID: 26874894
[TBL] [Abstract][Full Text] [Related]
27. CT densitometry in emphysema: a systematic review of its clinical utility.
Crossley D; Renton M; Khan M; Low EV; Turner AM
Int J Chron Obstruct Pulmon Dis; 2018; 13():547-563. PubMed ID: 29445272
[TBL] [Abstract][Full Text] [Related]
28. Alpha1-antitrypsin deficiency. 7: Computed tomographic imaging in alpha1-antitrypsin deficiency.
Shaker SB; Stavngaard T; Stolk J; Stoel B; Dirksen A
Thorax; 2004 Nov; 59(11):986-91. PubMed ID: 15516477
[TBL] [Abstract][Full Text] [Related]
29. [Long-term therapy of alpha 1-antitrypsin-deficiency-associated pulmonary emphysema with human alpha 1-antitrypsin].
Wencker M; Banik N; Buhl R; Seidel R; Konietzko N
Pneumologie; 1998 Oct; 52(10):545-52. PubMed ID: 9847632
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and radiological outcomes of lung nodules in alpha 1-antitrypsin deficiency.
Subramanian DR; Edgar R; Ward H; Parr DG; Stockley RA
Respir Med; 2013 Jun; 107(6):863-9. PubMed ID: 23337299
[TBL] [Abstract][Full Text] [Related]
31. Pattern of emphysema distribution in alpha1-antitrypsin deficiency influences lung function impairment.
Parr DG; Stoel BC; Stolk J; Stockley RA
Am J Respir Crit Care Med; 2004 Dec; 170(11):1172-8. PubMed ID: 15306534
[TBL] [Abstract][Full Text] [Related]
32. Densitometry for assessment of effect of lung volume reduction surgery for emphysema.
Stolk J; Versteegh MI; Montenij LJ; Bakker ME; Grebski E; Tutic M; Wildermuth S; Weder W; el Bardiji M; Reiber JH; Rabe KF; Russi EW; Stoel BC
Eur Respir J; 2007 Jun; 29(6):1138-43. PubMed ID: 17331971
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and impact of bronchiectasis in alpha1-antitrypsin deficiency.
Parr DG; Guest PG; Reynolds JH; Dowson LJ; Stockley RA
Am J Respir Crit Care Med; 2007 Dec; 176(12):1215-21. PubMed ID: 17872489
[TBL] [Abstract][Full Text] [Related]
34. Progress of emphysema in severe alpha 1-antitrypsin deficiency as assessed by annual CT.
Dirksen A; Friis M; Olesen KP; Skovgaard LT; Sørensen K
Acta Radiol; 1997 Sep; 38(5):826-32. PubMed ID: 9332238
[TBL] [Abstract][Full Text] [Related]
35. Quantitative assessment of emphysema distribution in smokers and patients with alpha1-antitrypsin deficiency.
Stavngaard T; Shaker SB; Dirksen A
Respir Med; 2006 Jan; 100(1):94-100. PubMed ID: 15882941
[TBL] [Abstract][Full Text] [Related]
36. Age related development of respiratory abnormalities in non-index α-1 antitrypsin deficient studies.
Holme J; Stockley JA; Stockley RA
Respir Med; 2013 Mar; 107(3):387-93. PubMed ID: 23276486
[TBL] [Abstract][Full Text] [Related]
37. Regional lung densities in alpha-1 antitrypsin deficiency compared to predicted values.
Stoel BC; Stolk J; Bakker ME; Parr DG
Respir Res; 2019 Feb; 20(1):45. PubMed ID: 30819163
[TBL] [Abstract][Full Text] [Related]
38. Long-term results after lung volume reduction surgery in patients with alpha1-antitrypsin deficiency.
Tutic M; Bloch KE; Lardinois D; Brack T; Russi EW; Weder W
J Thorac Cardiovasc Surg; 2004 Sep; 128(3):408-13. PubMed ID: 15354100
[TBL] [Abstract][Full Text] [Related]
39. Alpha-1 antitrypsin Null mutations and severity of emphysema.
Fregonese L; Stolk J; Frants RR; Veldhuisen B
Respir Med; 2008 Jun; 102(6):876-84. PubMed ID: 18353624
[TBL] [Abstract][Full Text] [Related]
40. Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE).
McElvaney NG; Burdon J; Holmes M; Glanville A; Wark PA; Thompson PJ; Hernandez P; Chlumsky J; Teschler H; Ficker JH; Seersholm N; Altraja A; Mäkitaro R; Chorostowska-Wynimko J; Sanak M; Stoicescu PI; Piitulainen E; Vit O; Wencker M; Tortorici MA; Fries M; Edelman JM; Chapman KR;
Lancet Respir Med; 2017 Jan; 5(1):51-60. PubMed ID: 27916480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
